title: HIV infection and hepatitis B seroprevalence among antenatal clinic attendees in Niger, West Africa.
abstract: This transversal study was suggested in order to estimate the nationwide seroprevalences of HIV infection and hepatitis B among 495 pregnant women in Niger in 2008. The study detected anti-HIV antibodies with Genscreen(®) Plus HIV Ag/Ab Ultra Kit (Bio-Rad; Hercules, CA), Vironostika(®) HIV Uni-Form II Ag/Ab (bioMérieux; Marcy-l'Etoile, France), and ImmunoComb(®) II HIV 1 and 2 BiSpot (Orgenics; Yavne, Israel). HBsAg was detected by Monolisa(®) HBsAg Ultra (Bio-Rad) and ImmunoComb(®) II HBsAg (Orgenics). The rates obtained were 2.02% (95% confidence intervals (CI): 1.03%-3.81%) and 16.16% (95% CI: 13.09%-19.77%), respectively. There were no significant variations according to environment, region, age, marital status, educational level, antecedent of surgery and transfusion. But these data need a large sample, and periodic updates for a better planning of activities in the framework of a national reproductive health program, including prevention of mother-to-child HIV transmission.
authors.affiliation: Laboratory of Bacteriology-Virology, Faculty of Health Sciences, University Abdou Moumouni, Niamey, Niger.
authors.forename: Saïdou
authors.initials: S
authors.lastname: Mamadou
authors.forename: Moussa
authors.initials: M
authors.lastname: Ide
authors.forename: Amadou Roufaï Ali
authors.initials: AR
authors.lastname: Maazou
authors.forename: Balki
authors.initials: B
authors.lastname: Aoula
authors.forename: Seyni
authors.initials: S
authors.lastname: Labo
authors.forename: Mamane
authors.initials: M
authors.lastname: Bozari